Skip to main content

Table 1 Data of the patients who underwent bronchoscopic IIT

From: Bronchoscopic intratumoral injection of tranexamic acid to prevent excessive bleeding during multiple forceps biopsies of lesions with a high risk of bleeding: a prospective case series

Case #, gender, age(years)

Location of lesion

AO (approx. %)

TEA nd/dd (mg)

EBB (n)

Histology

    Necrotic tumor (n = 8)

1 M(73)

RMB

80

250/120

10

SqCC

2 M(41)

RMB

90

250/120

5

SqCC

3 M(66)

RB3

100

250/120

3

SqCC

4 M(64)

RLLB

100

500/370

6

SqCC

5 M(72)

RBB

100

500/370

3

SqCC

6 M(58)

RULB

100

500/370

6

SqCC

7 M(64)

RULB

90

500/370

5

AC

8 M(80)*

LMB

100

500/370

5

MMT

     Hypervascular tumor (n = 12)

9 M(79)

RBI

70

250/120

4

SqCC

10 M(58)*

RMLB

90

250/120

3

SCLC

11 M(53)

LULB

100

500/370

4

SqCC

12 M(61)

LB4

80

500/370

5

SCLC

13 M(47)

RMB

90

500/370

6

SqCC

14 M(50)

LULB

50

500/370

7

AC

15 M(62)

RMB

90

500/370

9

SqCC

16 M(60)

Trachea-LMB

50-80

500/370

6

SqCC

17 M(59)

LULB

80

500/370

6

SCLC

18 M(64)

RULB

100

500/370

6

SqCC

19 M(53)

LULB

50

500/370

7

SqCC

20 M(67)

RBI

60

500/370

7

SqCC

  1. *Continuous dual antiplatelet therapy (aspirin and clopidogrel).
  2. AC- adenocarcinoma; AO-airway obstruction; dd-approximate delivered dose; EBB-endobronchial forceps biopsy; LB4- superior lingular segmental bronchus; LMB- left main bronchus; LULB- left upper lobe bronchus; MMT- malignant mesenchymal tumor; nd-nominal dose; RBB-right basal bronchus; RBI- Right bronchus intermedius; RB3- right upper lobe anterior segmental bronchus; RLLB -right lower lobe bronchus; RMB - right main bronchus; RMLB-right middle lobe bronchus; RULB-right upper lobe bronchus; SCLC- small-cell lung carcinoma; SqCC- squamous cell carcinoma; TEA-tranexamic acid.